A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Obesity (BMI ≥30 kg/m²) results from sustained energy imbalance; visceral adiposity (central obesity) is more pathogenic than subcutaneous fat, driving insulin resistance and inflammation via adipokine dysregulation (reduced adiponectin, elevated leptin, TNF-α, IL-6). Metabolic syndrome clusters obesity, dyslipidemia, hypertension, and insulin resistance, increasing cardiovascular and type 2 diabetes risk. Overnutrition (especially refined carbohydrates and ultra-processed foods) promotes adiposity and metabolic dysfunction; nutrient-dense, whole-food diets and physical activity can reverse many abnormalities. Weight loss of 5–10% improves metabolic markers; sustained weight loss requires both energy reduction and dietary composition optimization (whole grains, plant protein, omega-3s).
Analyze dietary records of obese versus healthy individuals; predict metabolic outcomes based on energy balance, macronutrient composition, and food quality.
You already understand energy balance: when caloric intake persistently exceeds expenditure, the surplus is stored primarily as triglycerides in adipose tissue. Obesity is sustained positive energy balance that expands adipose depots beyond their adaptive capacity. But the critical insight at this level is that not all fat tissue behaves the same way. Visceral adipose tissue — fat deposited around abdominal organs and drained directly into the portal circulation — is metabolically far more dangerous than subcutaneous fat. Visceral adipocytes are more lipolytically active, releasing fatty acids and inflammatory signals directly into the bloodstream supplying the liver. This portal delivery of excess free fatty acids drives hepatic insulin resistance and promotes dyslipidemia (high triglycerides, low HDL), connecting abdominal obesity to metabolic disease in a mechanistically direct way.
The adipose tissue of an obese person is not merely enlarged; it is functionally abnormal. In lean individuals, adiponectin — an anti-inflammatory, insulin-sensitizing adipokine — is abundantly secreted. As adipocytes enlarge, adiponectin production falls while pro-inflammatory adipokines rise: leptin (a satiety signal that loses effectiveness as resistance develops), TNF-α, and IL-6. Hypertrophied adipocytes also attract macrophages that further amplify the inflammatory signal. This low-grade chronic inflammation — sometimes called "metaflammation" — is the mechanistic bridge between excess adiposity and systemic metabolic dysfunction. Fat tissue in obesity is effectively behaving like chronically inflamed tissue.
Insulin resistance is the central metabolic consequence. Ectopic lipid accumulation in liver and skeletal muscle generates toxic intermediates (diacylglycerol, ceramides) that activate serine kinases. These kinases phosphorylate insulin receptor substrate-1 (IRS-1) at serine rather than tyrosine residues, impairing the downstream signaling cascade that would normally promote GLUT4 translocation to the cell surface. The result: cells cannot take up glucose efficiently even when insulin is present. The pancreatic beta cells compensate by secreting more insulin, maintaining euglycemia initially — but at the cost of progressive beta-cell exhaustion, eventually leading to type 2 diabetes.
Metabolic syndrome is the clinical clustering of five abnormalities driven by this underlying pathophysiology: abdominal obesity (waist circumference >102 cm in men, >88 cm in women), elevated triglycerides (≥150 mg/dL), low HDL cholesterol (<40 mg/dL in men, <50 mg/dL in women), elevated blood pressure (≥130/85 mmHg), and elevated fasting glucose (≥100 mg/dL). Meeting any three of these five criteria qualifies as metabolic syndrome. Each abnormality independently increases cardiovascular and diabetes risk; together they are multiplicative. The good news embedded in this pathophysiology is that even modest weight loss — as little as 5–10% of body weight — meaningfully reduces visceral fat, lowers inflammatory markers, improves insulin sensitivity, and partially restores adiponectin levels. Dietary composition also matters independently of calorie count: whole grains, plant proteins, and omega-3 fatty acids improve metabolic markers beyond what energy reduction alone achieves, suggesting that food quality shapes the inflammatory tone of adipose tissue, not only its size.